Skip to content

Dicyclomine

Published: July 26, 2026Updated: July 26, 2026

An antispasmodic drug that relieves symptoms of irritable bowel syndrome and gastrointestinal spasms by relaxing smooth muscles.

Quick summary

Dicyclomine is a prescription antispasmodic that relieves abdominal cramps and GI discomfort by relaxing intestinal smooth muscle.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
A03AA07
RxNorm
3361
Generic
Dicyclomine
Class
atc-a03
Brands
Bentyl
Availability
rx
Pregnancy
B
Lactation
safe
Routes
oral
Forms
injection, capsule, tablet, solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
20mg four times daily
Maximum
consult physician
Frequency
every 6 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
10mg three times daily
Maximum
consult physician
Frequency
every 8 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
10mg four times daily
Maximum
consult physician
Frequency
every 6 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose of 1000mg or more may cause serious anticholinergic toxicity in adults
Chronic overdose: Repeated doses exceeding 80mg daily over extended periods may lead to cumulative anticholinergic effects including cognitive impairment and urinary retention
Immediate actions
Supportive care including airway management, intravenous fluids, activated charcoal if within 1 hour of ingestion, monitoring of cardiac and respiratory function
Antidote
Physostigmine(May reverse central and peripheral anticholinergic effects within 15-30 minutes, use with caution due to risk of cholinergic crisis)
Poison Control: 1-800-222-1222

Special Populations

12 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh potential risks

Monitor

fetal monitoring as needed

Use with caution and monitor for adverse effects.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

avoid near term due to potential effects on uterine contractions

Monitor

monitor for preterm labor

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

discontinue breastfeeding or avoid drug, may pass into breast milk

Monitor

monitor infant for anticholinergic effects

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pediatric_age

infants
contraindicated
FDA Category
C
Dose Adjustment

contraindicated

Key Recommendations

do not use in infants due to risk of respiratory depression

Monitor

respiratory monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pediatric_age

children adolescents
unsafe
FDA Category
C
Dose Adjustment

not recommended

Key Recommendations

not recommended for use in children under 18 years

Monitor

not established for pediatric use

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

reduce dose, start low

Key Recommendations

use with extreme caution, start at lowest effective dose

Monitor

monitor for confusion, sedation, urinary retention

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild
caution
FDA Category
C
Dose Adjustment

no adjustment needed

Key Recommendations

use with caution, monitor renal function

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate to severe
caution
FDA Category
C
Dose Adjustment

reduce dose

Key Recommendations

use lower dose and monitor closely

Monitor

frequent renal function monitoring

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

use with caution, monitor liver function

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use or use very low dose with extreme caution

Use of this medication in this population requires careful consideration of risks and benefits.

✗

alcohol_users

concurrent use
unsafe
FDA Category
C
Dose Adjustment

avoid alcohol

Key Recommendations

avoid alcohol while taking this medication

Monitor

monitor for excessive sedation

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Antispasmodic (Anticholinergic)

Dicyclomine belongs to the antispasmodic and anticholinergic drug class

usageFDA
2023

Common uses

Value:Irritable bowel syndrome (IBS), gastrointestinal spasms

Primary therapeutic indications for Dicyclomine

mechanismPharmacological organizations
2023

Mechanism of action

Value:Anticholinergic - blocks acetylcholine receptors

How Dicyclomine works to relieve smooth muscle spasms

prescribingFDA
2023

Commonly prescribed since

Value:1960s

Historical prescribing information for Dicyclomine

Treatment of irritable bowel syndrome (IBS), functional gastrointestinal disorders, and other conditions characterized by smooth muscle spasms of the gastrointestinal tract causing abdominal pain, cramping, and discomfort.

Dicyclomine acts as an anticholinergic (antimuscarinic) agent, blocking acetylcholine at muscarinic receptors on smooth muscle cells in the gastrointestinal tract. This dual mechanism helps relax intestinal smooth muscle and reduces spasms that cause pain and discomfort.

May cause drowsiness, dry mouth, blurred vision, and constipation. Patients with glaucoma, urinary retention, or severe ulcerative colitis should use with caution. Alcohol may enhance sedative effects. Should be taken exactly as prescribed by a healthcare provider.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy